The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Alveolar hemorrhage (AH), diffuse AH (DAH)
Publications
Ben Mrad I, Ben Mrad M, Oumaya Z, Zairi I, Besbes B, Ouaghlani K, Kamoun S, Mleyhi S, Miri R, Mzoughi K, Kraiem S
Alveolar Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction: Two Case Reports and Literature Review.
Open access emergency medicine : OAEM. 2021;13:399-405
Pulmonary haemorrhage following thrombolysis with streptokinase in myocardial infarction.
BMJ case reports. 2020;13(1)
[Alveolar hemorrhage as a complication of thrombolytic therapy].
Medicina. 2011;71(6):547-9
Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction.
Respiration; international review of thoracic diseases. 2000;67(4):445-8
Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction.
International journal of cardiology. 1998;63(1):95-7
Diffuse pulmonary hemorrhage after streptokinase administration for acute myocardial infarction.
Pharmacotherapy. 1997;17(2):390-4
Spontaneous pulmonary hemorrhage after thrombolytic therapy for acute myocardial infarction.
Chest. 1994;106(5):1622-4
Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction.
International journal of cardiology. 1990;29(3):387-90